rs6350

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001044.5(SLC6A3):​c.114C>T​(p.Asn38Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0642 in 1,614,116 control chromosomes in the GnomAD database, including 3,584 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 275 hom., cov: 33)
Exomes 𝑓: 0.065 ( 3309 hom. )

Consequence

SLC6A3
NM_001044.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.485

Publications

49 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 5-1443084-G-A is Benign according to our data. Variant chr5-1443084-G-A is described in ClinVar as Benign. ClinVar VariationId is 522348.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.485 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0623 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.114C>T p.Asn38Asn synonymous_variant Exon 2 of 15 ENST00000270349.12 NP_001035.1 Q01959

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.114C>T p.Asn38Asn synonymous_variant Exon 2 of 15 1 NM_001044.5 ENSP00000270349.9 Q01959
SLC6A3ENST00000713696.1 linkc.114C>T p.Asn38Asn synonymous_variant Exon 2 of 15 ENSP00000519000.1
SLC6A3ENST00000713698.1 linkc.114C>T p.Asn38Asn synonymous_variant Exon 2 of 5 ENSP00000519002.1
SLC6A3ENST00000713697.1 linkn.114C>T non_coding_transcript_exon_variant Exon 2 of 11 ENSP00000519001.1

Frequencies

GnomAD3 genomes
AF:
0.0587
AC:
8935
AN:
152144
Hom.:
275
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0508
Gnomad AMI
AF:
0.0846
Gnomad AMR
AF:
0.0557
Gnomad ASJ
AF:
0.0438
Gnomad EAS
AF:
0.0160
Gnomad SAS
AF:
0.0561
Gnomad FIN
AF:
0.0840
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0639
Gnomad OTH
AF:
0.0630
GnomAD2 exomes
AF:
0.0556
AC:
13978
AN:
251432
AF XY:
0.0574
show subpopulations
Gnomad AFR exome
AF:
0.0516
Gnomad AMR exome
AF:
0.0343
Gnomad ASJ exome
AF:
0.0416
Gnomad EAS exome
AF:
0.0184
Gnomad FIN exome
AF:
0.0805
Gnomad NFE exome
AF:
0.0639
Gnomad OTH exome
AF:
0.0588
GnomAD4 exome
AF:
0.0648
AC:
94667
AN:
1461854
Hom.:
3309
Cov.:
34
AF XY:
0.0646
AC XY:
46946
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0490
AC:
1640
AN:
33480
American (AMR)
AF:
0.0365
AC:
1631
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0417
AC:
1090
AN:
26136
East Asian (EAS)
AF:
0.0128
AC:
507
AN:
39700
South Asian (SAS)
AF:
0.0608
AC:
5241
AN:
86258
European-Finnish (FIN)
AF:
0.0779
AC:
4160
AN:
53420
Middle Eastern (MID)
AF:
0.0824
AC:
475
AN:
5768
European-Non Finnish (NFE)
AF:
0.0684
AC:
76019
AN:
1111972
Other (OTH)
AF:
0.0646
AC:
3904
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5431
10861
16292
21722
27153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2828
5656
8484
11312
14140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0588
AC:
8950
AN:
152262
Hom.:
275
Cov.:
33
AF XY:
0.0602
AC XY:
4485
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0510
AC:
2118
AN:
41544
American (AMR)
AF:
0.0556
AC:
851
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0438
AC:
152
AN:
3472
East Asian (EAS)
AF:
0.0160
AC:
83
AN:
5186
South Asian (SAS)
AF:
0.0570
AC:
275
AN:
4824
European-Finnish (FIN)
AF:
0.0840
AC:
891
AN:
10612
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0638
AC:
4342
AN:
68008
Other (OTH)
AF:
0.0629
AC:
133
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
429
859
1288
1718
2147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0593
Hom.:
705
Bravo
AF:
0.0559
EpiCase
AF:
0.0692
EpiControl
AF:
0.0651

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Classic dopamine transporter deficiency syndrome Benign:2
Apr 07, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parkinsonism-dystonia, infantile Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.28
DANN
Benign
0.55
PhyloP100
-0.48
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6350; hg19: chr5-1443199; API